Sign in

CIK 0001649904

  • Large accelerated filer

RHYTHM PHARMACEUTICALS, INC.

Sign in to watch
Ticker
RYTM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
462159271
Phone
+1 857-264-4280
Business address
222 BERKELEY STREET, 12TH FLOOR, BOSTON, MA, 02116
Former names
RHYTHM METABOLIC, INC.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$11,753,355
in 2 filings, $11.8M under 10b5-1 plans

Net −$11,753,355. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-08-13 Lee Jennifer Kayden EVP, Head of North America Exercise or conversion 10b5-1 +35,000 $24.29 $850K 54,233
2026-08-13 Lee Jennifer Kayden EVP, Head of North America Exercise or conversion 10b5-1 +21,601 $6.80 $147K 75,834
2026-08-13 Lee Jennifer Kayden EVP, Head of North America Sale 10b5-1 −75,834 $117.38 $8.9M 0
2026-08-13 Lee Jennifer Kayden EVP, Head of North America Exercise or conversion · Stock Options (Right to Buy) 10b5-1 −35,000 36,283
2026-08-13 Lee Jennifer Kayden EVP, Head of North America Exercise or conversion · Stock Options (Right to Buy) 10b5-1 −21,601 0
2026-02-11 Lee Jennifer Kayden EVP, Head of North America Grant or award · Restricted Stock Units +21,650 21,650
2026-02-11 Lee Jennifer Kayden EVP, Head of North America Grant or award · Stock Options (Right to Buy) +32,500 32,500
2026-02-01 Lee Jennifer Kayden EVP, Head of North America Exercise or conversion +22,612 28,470
2026-02-01 Lee Jennifer Kayden EVP, Head of North America Shares withheld for taxes −9,237 $108.99 $1.0M 19,233
2026-02-01 Lee Jennifer Kayden EVP, Head of North America Exercise or conversion · Restricted Stock Units −3,437 0
2026-02-01 Lee Jennifer Kayden EVP, Head of North America Exercise or conversion · Restricted Stock Units −4,512 4,512
2026-02-01 Lee Jennifer Kayden EVP, Head of North America Exercise or conversion · Restricted Stock Units −5,500 11,000
2026-02-01 Lee Jennifer Kayden EVP, Head of North America Exercise or conversion · Restricted Stock Units −9,163 27,487
2025-02-19 Lee Jennifer Kayden EVP, Head of North America Sale 10b5-1 −2,035 $57.22 $116K 5,858
2025-02-16 Lee Jennifer Kayden EVP, Head of North America Exercise or conversion 10b5-1 +5,500 7,893
2025-02-16 Lee Jennifer Kayden EVP, Head of North America Exercise or conversion · Restricted Stock Units 10b5-1 −5,500 16,500
2025-02-14 Lee Jennifer Kayden EVP, Head of North America Grant or award · Restricted Stock Units 10b5-1 +36,650 36,650
2025-02-14 Lee Jennifer Kayden EVP, Head of North America Grant or award · Stock Options (Right to Buy) 10b5-1 +55,000 55,000
2025-02-13 Lee Jennifer Kayden EVP, Head of North America Sale 10b5-1 −1,205 $58.00 $70K 2,393
2025-02-12 Lee Jennifer Kayden EVP, Head of North America Sale 10b5-1 −600 $56.39 $34K 4,813

Page 1 of 5 · 86 trades